| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2017/02/15 | 08 : 15 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2017/02/15 | 02 : 46 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/11/05 | 05 : 03 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/31 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 12 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 09 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 07 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 05 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/26 | 05 : 02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/25 | 21 : 53 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/25 | 20 : 57 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/25 | 20 : 56 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/22 | 06 : 01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/17 | 21 : 30 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/17 | 21 : 19 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/12 | 02 : 50 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |
| 2016/10/05 | 05 : 30 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:VTAE | Vitae Pharmaceuticals, Inc. (MM) |